glutathione infusion IV Therapy: Detox, Brighten Skin & Boost Immunity Glutathione IV Drip Mumbai: The

LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al

Gastrointestinal protection: BPC-157 was originally discovered in gastric juice and has been shown to protect the gastrointestinal tract from damage caused by various agents, such as NSAIDs (nonsteroidal anti-inflammatory drugs), alcohol, and stress

Low-dose cadmium exposure unexpectedly enhanced cattle growth by improving the feed-to-gain ratio

It is currently in clinical trials as a treatment option for adults with type 2 diabetes (T2DM) and obesity